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ABSTRACT
The metabolic control of citrate synthase by the inhibitory 
effect of ATP has been repeatedly proposed. The reaction catalysed by 
citrate synthase in crude extracts of several tissues is shown to be 
inhibited by ATP. This inhibition is competitive with respect to acetyl- 
CoA. Low levels of Mg"*"*, however, relieve the inhibition by ATP and 
%  concentrations one hundred fold greater than acetyl-CoA concentra­
tion inhibit the citrate synthase catalysed reaction. The suggestion 
has been made that Mg'*4’ binds to the polyphosphate group of acetyl-CoA 
so that it is unable to interact with the enzyme. Similarly, Mg++ may 
bind with the polyphosphate group of ATP so that it cannot act as an 
inhibitor for the enzymatic reaction. In vitro studies of complex
-I |  *f“ | '
formation between Mg and ATP support this suggestion. When Mg and 
ATP are present in equal concentration during the citrate synthase 
reaction, no inhibition is observed. Results of these experiments are 
considered in terms of the citrate synthase reaction mechanism and of 
metabolic control and bring into doubt the role of ATP as a metabolically 
significant controller.
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CHAPTER 1
INTRODUCTION
A. STOICHIOMETRY
Citrate synthase (citrate oxalacetate-lyase(CoA-acetylating)
EC 4.1,3.7) catalyzes the condensation of OAA with acetyl-CoA to fora 
citrate and CoA (equation i):
OAA~ + acetyl-CoA + HgO citrate* + CoA + H+
(equation i)
This aldol condensation involves the methyl group of the acetyl moiety 
in acetyl-CoA and the carbonyl of OAA, In the early days of investi­
gation, acetic acid itself was known not to take part in the enzymic 
reaction; thus, the notion of an active acetate came about (1). Evidence 
was found to support the supposition that the active acetate was formed 
by oxidation of fatty acids from ft -keto acids such as acetoacetic acid 
and from acetic acid (2,3,^,5*6,7,8,9,10). Then it became apparent 
that a coenzyme was necessary for these acetylation reactions (11,12), 
This coenzyme was called coenzyme A (13), Isolation and purifi­
cation showed that it was composed of pantothenic acid, adenylic acid or 
a related nucleotide (1^ ,15) and a sulfhydryl compound attached to the 
pantothenic acid (15,16). The sulfur compound was then shown to be 
^-mercaptoethanolamine attached to pantothenic acid by a peptide bond 
(17,18). Previous experiments using yeast cells deficient in pantothenic 
acid indicated that CoA could be involved in the formation of citric acid 
(19), Using a soluble enzyme preparation, Stern and Ochoa synthesized 
citrate from OAA, acetate and ATP; CoA was required for activity (20),
'1
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2Acetoacetate and other/3-keto acids (21) were acetyl donors during citrate 
formation in pigeon liver preparations. Stadtman then reported (22) 
that CoA functioned as an acetyl transfer agent in a pho sphotransacetylase 
system from bacteria. Novell! and Lipmann (23) found that acetyl phos­
phate was an acetyl donor for citrate synthesis. These facts led Stem 
and Ochoa (2*0 to propose the formation of acetyl-CoA from acetyl phos­
phate and CoA; subsequent interaction of acetyl-CoA with OAA formed 
citrate and CoA.
Lynen and Reichert (25) isolated acetyl-CoA from yeast and showed 
that this substance could replace either acetate and ATP or acetyl phos­
phate as an acetyl donor in the acetylation of sulfonamide by a crude 
extract of pigeon liver. A similar function for acetyl-CoA was found 
in the acetylation of p-aminobenzoic acid (26,27). Then, Stern using 
crydfalline CS demonstrated that in place of the transacetylase-acetyl 
phosphate system, acetyl-CoA could fill the role of acetyl donor in the 
synthesis of citrate. Upon studying the properties of acetyl-CoA,
Stadtman (29) confirmed the conclusions of Lynen and Reichert (25) that 
the acetyl group of acetyl-CoA was attached by thioester linkage to the 
thioethanolamine moiety of CoA. Stern (30)* by measuring the quantities 
of substrates and products at equilibrium, found that citrate synthase 
had a high affinity for acetyl-CoA and that the acetyl-mercaptide bond 
of acetyl-CoA was energy rich. They reported the apparent equilibrium 
constant of the overall reaction to be 8.38 x 10^ litres/mol© at pH 7.2 
and 22° C. .
B. MECHANISM
All this investigation led to further experiments which attempted
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
to show th© mechanism of the CS catalysed reaction. It was known that a 
carbon-carbon bond is formed between the methyl carbon of acetyl-CoA and 
the carbonyl of OAA. This may be considered a mixed aldol condensation.
It was also known that non-enzymatically, these reactions take place 
when a proton c( to a carbonyl is lost. This rate-determining step is 
followed by the attack of this anion on the positively-charged carbonyl 
carbon of another reacting molecule. Bove (31). investigating this 
aspect of the CS reaction, showed that OAA had to be present in order 
that tritium be incorporated into the terminal methyl group of acetyl-CoA 
from the medium. When acetyl-CoA, tritiated in the acetyl group, took 
part in the enzymatic reaction, loss of radioactivity in the coenzyme 
occurred. It was concluded that OAA was necessary for removal of an 
©(-hydrogen from the acetyl group of acetyl-CoA and that this loss was 
rate-determining. Similar conclusions were reached by Marcus and 
Vennesland (32) who used D^O, Englard (33) used deuterated OAA to show 
that the keto form of OAA is the reactive tautomer in the CS reaction.
Srere and Kosicki (3*0 devised a method of purification for CS 
and reported the CS content of a variety of tissues. Under the conditions 
used, the amount and purity of the enzyme were increased over previous 
methods. Using an enzyme of high purity, they studied the effect of pH 
on Vraax, Km and the rates of the forward and reverse reactions (35). It 
was found that the pH optimum was different for the forward and reverse 
reactions. Dalzlel*s kinetic expression (36) for a two-substrate reaction, 
where one substrate may act as a competitive inhibitor, fit the data0 
From experiments using normal and deuteroacetyl-CoA in H2O and DgO (3?)» 
Kosicki and Srere concluded that the removal of a proton from the c(-methyl
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
group of acetyl-CoA was rate-limiting or very nearly so. They also 
observed a shift in the activity curve of CS in the presence of DjjO. If 
the enzyme-substrate complex reacts maximally when particular groups on 
the complex are dissociated, the more tightly bonded deuterium would be 
expected to shift the pH dependent activity curve in the direction observed 
in these experiments. These are similar to findings with lactate dehydro­
genase (38)• During a study of the binding of OAA to CS, Srere found 
that formation of an OAA-enzyme complex is accompanied by a change in 
protein conformation (39.^0)• Preincubation of the enzyme with OAA 
prevents exposure in urea of protected sulfhydryl groups and loss of 
activity (hi,^2). Srere (h3) has concluded that the sulfhydryl groups 
of CS are involved in Internal hydrogen bonding for maintenance of a 
particular conformation at the active site; these sulfhydryl groups do 
not take part directly in the enzyme-catalysed reaction. OAA also 
protects CS from heat denaturation (hh) and from palmitoyl-CoA inhibi­
tion (h5,h6). This property may have importance for control of enzyme 
activity (h7)e
Evidence indicates that OAA is bound to CS through both carboxyl 
groups and through the carbonyl oxygen (ho). The spectral changes 
observed when OAA binds to CS were interpreted to indicate a compacting 
of the protein (39)• In terms of mechanism, these observations support 
the earlier finding that exchange between the o<I-methyl proton of acetyl-CoA 
and the medium occurs only in th© presence of both enzyme and OAA (31,32).
By measuring the incorporation of tritium into the acetyl group of 
acetyl-CoA, Eggerer (^8) showed that L-malate aided in the removal of a 
proton from the acetyl group of acetyl-CoA. Srere (^9)» by means of 
nuclear magnetic resonance, measured the ability of several compounds
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
to induce the loss of this proton from acetyl-CoA in a system containing 
CS and D20 medium. The results were similar to those of Eggerer,
Maleate, D-malate, pyruvate, dimethylglutarate and succinate allowed no 
exchange of protons, L-Malate or OAA induced proton removal.
When OAA becomes bound to the active site of CS, there occurs in 
the enzyme a conformational change (only partial when L-malate is used) 
which brings a group on the enzyme into a more favorable position for 
removal of the <X-methyl proton of acetyl-CoA (**9).
The nature of the thioester linkage in acetyl-CoA makes it suit­
able as an acetyl donor. Sulfur is electronegative (i.e. willing to 
accept electrons) and has unfilled d orbitals just above the outer electron 
shell. These are not very different in energy from the outer p orbitals. 
Since sulfur's electronic configuration is only two electrons short of 
the corresponding rare gas, this element forms stable anions. At 
physiological pH and temperature, acetyl-CoA is stable. Since sulfur 
tends to hold on to its electrons, it tends not to participate in 
resonance. When an acetyl group is attached to a sulfur as in acetyl-CoA, 
the electronegativity of oxygen polarizes the C=0 bond in the direction 
of oxygen. Similarly, the electrons of the C-S bond are polarized 
toward sulfur (50). This leaves the carbonyl carbon relatively positive. 
This in turn causes polarization of a C-H bond. A proton is released - 
and the carbanion formed is stabilized by resonance (Diagram i). Since 
this proton loss from acetyl-CoA requires the presence of both OAA and CS, 
this reaction ’takes place in an environment in which spatial arrangement 
and electronic configuration of atoms are specific and transitional. The 
attack of the carbanion on the carbonyl of OAA is followed by a nucleo- 
philic substitution at the acyl carbon of acetyl-CoA (51) with simultaneous
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1 ftcleavage of the acyl-sulfur bond. Suelter and Arrington (52) used H2O 
to show that oxygen from H2O in the medium becomes associated with the 
carboxyl of citrate derived from acetyl-CoA. Then as suggested by 
Eggerer (^8), CS has the following three catalytic functions; enolase, 
ligase and hydrolase (Diagram 2).
*0- (
9 +  ■ _  9
H-CH2-C-SCoA H + CH2-C-SC0A
-0
CH2-C-SCoA
Diagram 1
-0- 9=0
0=C CH0-C-SC0A enolase
H
-  0- 9=0 0
~ 0-C+<-CH2-b-SCoA ligase
6h?
-  0-6=<) H+
0- 9=0 "0
O-C-CH2-C....SCoA hydrolase
9H2 i +
0-C=0 'OH H
Diagram 2
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7C. METABOLIC CONTROL
The reaction catalyzed by CS merits consideration since it occupies 
a position in metabolism where carbohydrate, fat and protein metabolism 
merge and diverge, Oxalacetate, pyruvate and^-ketoglutarate may be 
formed respectively from aspartate, alanine and glutamate by transamination, 
Acetyl-CoA, a substrate in the CS reaction, may enter the tricarboxylic 
acid cycle by way of this reaction or, by means of acetyl-CoA carboxylase, 
take part in the synthesis of malonyl-CoA to eventually form long chain 
fatty acidsj acetyl-CoA may be transformed to keto acids such as aeeto- 
acetate or return to glucose during gluconeogenesis. Therefore, it is 
probable that control of the CS reaction is well integrated with other 
pathways by means of one or more mechanisms.
The observed in vivo activity of an enzyme depends on how much 
enzyme is present and on the state of these molecules —  their ability to 
act as catalysts. Although th© enzyme content of a tissue may have a 
role in control of CS activity, it has generally been found that de novo 
synthesis and degradation of enzyme molecules would take place too slowly 
to be effective as a fine control (53)• Previous observations have shown 
that changes in conformation of proteins do occur on association with 
protons, substrate or product molecules, coenzymes, metal ions or other 
proteins resulting in simultaneous changes in activity. Thus, metabolism 
may be regulated at the enzyme level by availability of modifiers of 
protein (enzyme) structure.
This availability is controlled by synthesis and degradation of 
modifiers, by transport across membranes or by competition for modifiers 
between proteins (enzymes) and other molecules or ions.
Stem and Ochoa (24-) reported that ATP inhibited the synthesis of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
8citrate in a soluble enzyme system prepared from acetone-dried pigeon 
liver* Yeast CS kinetic properties were altered in the presence of 
adenine nucleotides (5*0« ATP when present in physiological concentrations 
altered the activity more than other nucleotides. A control mechanism 
analogous to isocitrate dehydrogenase was proposed for CS, NAD-specific 
isocitrate dehydrogenase had been shown (55) to possess increased activity 
in the presence of AMP and decreased activity in the presence of ATP. 
Therefore, it was proposed that ATP regulation of CS activity was part 
of a mechanism by which the energy state of the cell (proportional to the 
ATP level) controlled the fate of acetyl-CoA. The finding that citrate 
stimulates acetyl-CoA carboxylase (56,57*58) implied added importance to 
the speculation that regulation of CS activity directs acetyl-CoA incorp­
oration into fatty acids or into the tricarboxylic acid cycle (5*0 *
ATP inhibition of CS is competitive with acetyl-CoA in pig heart 
(5**»59) * yeast (5*0* beef heart, beef liver, and Escherischia coli (60,61). 
ATP also inhibits this enzyme from rat liver mitochondria (62) and lemon (63). 
Jangaard recently reported (6 )^ that ATP inhibition of partially purified 
Escherischia coli CS was not competitive with respect to acetyl-CoA. Kosicki 
and Lee (59) have shown that pig heart CS is inhibited by ATP, ADP, GTP,- 
GDP, ITP, IDP, palaitoyl-CoA, NADH and NADPH, In each case, however, the • 
inhibition is relieved by increasing concentration of acetyl-CoA. Furthermore, 
the metal ions Mn++, Mg**, and Ca**, which inhibit the reaction competi­
tively with respect to acetyl-CoA at low concentration, relieve the 
inhibition of -the nucleotide derivatives. It is suggested (59,65) that 
this relief of inhibition is due to chelation of divalent metal ion with 
the polyphosphate portion of the inhibitor molecules. By this reasoning, 
the inhibition of the CS reaction by metal ions is interpreted to mean
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
that in the normal reaction acetyl-CoA becomes bound to the enzyme through 
its polyphosphate group (65). These observations of divalent metal ion 
relief of inhibition bring into serious question whether ATP in vivo plays 
a role in the regulation of CS because of the high physiological level of
In order to determine whether these characteristics of inhibition 
of the CS catalysed reaction are significant to the control of the reaction, 
we have used crude extracts of a number of tissues. Experimental design 
and treatment of data were carried out in order to answer the following: 
Does ATP always inhibit CS? Is this inhibition competitive with respect 
to acetyl-CoA? Does Mg++ relieve this inhibition?
It was found that in each of the tissues studied, ATP inhibition 
of CS was competitive with respect to acetyl-CoA, and Mg relieved the 
inhibition. These results are in agreement with previous findings that 
ATP inhibits CS competitively with respect to acetyl-CoA (5^.59.60,61,65)• 
Mg++ relieves the inhibition due to ATP and optimum activity is observed 
when ATP and Mg are present in concentrations having a 1/1 ratio as 
previously reported (59.65). In experiments using a wide concentration 
range of ATP and a concentration of Mg++ such that the ATP/Mg++ ratio 
was one, no inhibition was observed.
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CHAPTER 2
\
EXPERIMENTAL
A. METHODS
1) Growth of Yeast Cells
University of Windsor, Department of Biology, colony #195 
Saccharotnyces carlsbergensls was used. Cells were grown in media consisting 
of: 3*5 g peptone, *1-0.0 g dextrose, 2.0 g K^POi*, 5*0 g yeast extract and 
1000 ml of water. For aerobic growth, a 100 ml inoculum was added to the 
media and growth allowed to proceed for 26 hours at 2*J-°C with continuous 
stirring with a bar magnet. For anaerobic growth, a loopful of cells was 
used to inoculate media which had been flushed with nitrogen gas for 6 
hours. Growth was allowed to proceed for days at 37°G. Nitrogen gas 
was bubbled through the media continuously. Cells were spun down, washed 
once in 0.1 M potassium phosphate buffer, pH 7.**, and frozen.
2) Preparation of Crude Extracts
The initial steps of the method of- Srere and Kosicki (3*0 for
the isolation of CS were used to prepare crude extracts. In this method,
10 g of tissue were extracted with *M) ml of 20 per cent ethanol, 0.** M in 
potassium chloride. Homogenization in a Waring blendor was carried out 
for 10 minutes and the temperature was not allowed to exceed 18°C. In 
the case of the yeast cells, an amount of glass powder equal to the weight 
Of the yeast cells was used during homogenization. The homogenate was 
centrifuged for 15 minutes at 23,000 x g and the supernatant fluid dialyzed 
against 800 ml of cold 0.002 M potassium phosphate pH 7.3 for 2 hours. The 
outside fluid was changed and dialysis continued for another two hours.
The dialysate was centrifuged at 23,000 x g for 15 minutes. The supernatant
10
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fluid was used for enzyme assays and is stable for several days at 3°C. 
Protein determinations were made using the Biuret method (66).
3) Enzyme Assay Method'  • ■ ■ a m b ' i M i  masaBM aanaea* rwwTwtnTawm h jb
CS activity was assayed using a coupled assay procedure. In 
this assay, L-malate, NAD and an excess of MDH are used to generate OAA:
L-malate + NAD+ - o M  + NADH + H+
CS catalyzes the condensation of the acetyl group of acetl-CoA with OAA:
OA/f + 9H2-C-SCoA + HgO r;-.-C-9 citrate- + CoASH + H+
Therefore, as long as the MDH catalyzed reaction is not rate-limiting, the 
rate of the CS catalyzed reaction may be followed by observing the reduction 
of NAD at 3*K> raja. The molar absorbancy of NADH is 6220,
Tris-acetate buffer, L-malate, NAD, acetyl-CoA, MDH and deionized 
water were incubated at 25°C for 3 to k minutes. During this time the MDH 
catalyzed reaction comes to equilibrium. The CS reaction was then initiated
by the addition of crude extract and the rate recorded on a Gilford Model
2000 Absorbance Recorder attached to a Beckman DU Monochromator, The 
temperature of the reaction chamber was kept constant at 25,0 1 0,2°C by 
a circulating water bath. The rate was linear for at least five minutes 
after the start of the reaction and was measured over the time range from 
2 to k minutes after initiation of the reaction.
Each extract was also assayed for NADH oxidase activity and this 
was found to be negligible in all cases examined (A.O.D./minute at 3^0 nya 
< 0.003) .
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h) Materials
The following were obtained commercially: L-malic acid, ATP 
(Sigma); NAD, bovine serum albumin (Calblochem); CS, CoA, NADH and MDH 
(Boehringer and Soehne, Mannheim), KHCO^, MgCl2‘6H20, K^PO^, K2HP0^
(Fisher) and acetic anhydride (Eastman) were reagent grade, Tris was 
primary standard grade,
L-Malic acid, ATP and NAD were dissolved in water and the pH 
adjusted to neutrality with solid KHCO3. NADH was dissolved in 0.1 M 
Tris-acetate buffer pH 8.2 . Molar Tris-acetate buffer was prepared by 
adding molar acetic acid to molar Tris until the desired pH was reached. 
Similarly, molar phosphate was prepared using molar solutions of KH2PO4 
and K2HP0j^ .
Commercial CS, MDH and crude extracts were diluted in 0,02 M 
potassium phosphate buffer pH 7«3 containing 1 mg/ml of bovine serum 
albumin, ■
Acetyl-CoA was prepared according to the method of Simon and 
Shemin (67). CoA is very hygroscopic making it difficult to weigh small 
amounts accurately; it was important to know the concentration of acetyl- 
CoA for the competitive inhibition studies. Therefore, the concentration 
of acetyl-CoA in the prepared stock solution was determined by using a 
measured amount of this substrate in the coupled assay system containing 
an excess of commercial CS, After ten minutes, when the reaction was completed, 
the amount of NADH formed was measured at 3^0 rap. against a reaction 
mixture containing no acetyl-CoA (blank), Since one molecule of NADH is 
formed for each molecule of acetyl-CoA reacting, and the CS reaction goes 
to completion, then the concentration of NADH at the end of the reaction 
equals the initial concentration of acetyl-CoA.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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5) Calculations
Km is defined as being numerically equal to the concentration 
of the substrate which permits half-maximal velocity. Ki is the concentra­
tion of the inhibitor that slows the reaction to half the rate observed 
when no inhibitor is present. In these studies, Km and Ki were calculated 
using Lineweaver-Burk plots of reciprocal of initial velocity versus 
reciprocal of substrate concentration (68). Initial velocities (V0) were 
calculated from the slopes of the chart paper data and were in units of 
AO.D./minute at 3^0 mp. The reciprocal of these values and the corresponding 
reciprocal substrate (acetyl-CoA) concentration along with the least 
squares program shown in the APPENDIX were run on an IBM 1620^ computer.
Data from both uninhibited and inhibited runs were treated in this way.
The computer chose the line of best fit for the uninhibited run and 
another line for the inhibited run. From the slopes and x-axis intercepts 
of these lines, Km and Ki were calculated,.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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B. RESULTS
1) Inhibition of CS by ATP
ATP in a concentration 20 to 200 times that of acetyl-CoA 
inhibits CS in a crude extract of beef heart. The inhibition is com­
petitive with respect to acetyl-CoA as shown by a Lineweaver-Burk plot 
(68, Fig. 1). ATP has the same inhibitpry effect on CS in crude extracts 
of beef liver, rat heart, liver, kidney and brain, and aerobically and 
anaerobically grown yeast (Table 1, columns d and e). Increasing concen­
trations of ATP led to a decline in CS activity until a minimum level was 
reached at about 80 per cent of control (Fig. 2).
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Fig. i. Competitive inhibition of ATP on CS activity 
in a crude extract of beef heart.
The coupled assay procedure was used. Each cuvette (1.0 cm light 
path) contained 0.20 M Tris-acetate buffer pH 8.36, 10 raM malate, 
0.384 mM NAD, 7»2 units of MDH, beef heart crude extract containing 
0.007 units of CS, acetyl-CoA and ATP as indicated and water to 
lo0 ml final volume.
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Fig. 2. Effect of ATP concentration on the rate of 
the CS catalysed reaction in a crude extract of beef heart.
The coupled assay procedure was used. Each cuvette (1.0 cm light 
path) contained 0.20 M Tris-acetate buffer pH 8*30, 10 mM malate, 
0.38** mM NAD, 108.0 acetyl-CoA, 8.0 units of MDH, 0.00** units 
of CS in a beef heart crude extract, ATP as indicated and water 
to 1.0 ml final volume. Potassium chloride was added in 
appropriate amounts from a stock solution to maintain a constant 
ionic strength from one reaction to another. The ionic strength 
due to ATP and KC1 was 0.2*10 .
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2) Effect of Mg~H ~ on ATP inhibition of citrate synthase
In the absence of Mg , concentrations of ATP approximately 75 
times (5 raM ATP) and 150 times (10 mM ATP) that of acetyl-CoA are 
inhibitory to CS in a beef heart crude extract (compare the y-axis 
intercepts of the curves in Fig. 3» See also Table I, columns f and h).
-J- |
Increasing concentrations of Mg are also inhibitory to CS (upper curve
Fig. 3)• In the presence of a fixed amount of ATP, increasing concentrations 
++
of Mg lead to an increase in activity of CS (Table I, compare column f
with g and h with i) followed by a gradual decline in activity (Fig. 3)»
maximum activity is observed when ATP and %  are present in approximately
equal concentrations (two lower curves of Fig. 3)« When a wide range
of ATP concentrations is used in the presence of equal concentrations 
++
of 1% , no inhibition is observed (Fig. b). A comparison of Figs. 2
and b indicates the effect of Mg++ on the ATP inhibition of CS.
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Fig. 3» Effect of Mg++ on ATP inhibition of CS in a 
crude extract of beef heart.
The coupled assay procedure was used. Each cuvette (1.0 cm light 
path) contained 0.20 M Tris-acetate buffer pH 8.33» 10 mM malate, 
0.38^ nsM NAD, 65.^  acetyl-CoA, 7*2 units of MDH, beef heart 
crude extract containing 0.007 units of CS, ATP and Mg++ as 
indicated and water to 1.0 ml final volume.
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Fig. Effect of concentration of ATP on the rate 
of the reaction catalyzed by CS in a crude extract of beef heart 
when Mg is present in a concentration equal to that of ATP.
The coupled assay procedure was used. Each cuvette (i.O cm 
light path) contained 0,20 M Tris-acetate buffer pH 8.30, 10 mM 
malate, 0.38^ mM NAD, 133*2 /iM acetyl-CoA, 8.0 units of MDH,
0.00^ units of CS in a beef heart crude extract, ATP and Mg++ 
as indicated and water to 1.0 ml final volume. Potassium chloride 
was added in appropriate amounts to maintain a constant ionic 
strength from one reaction to another. The ionic strength due 
to ATP, Mg** and KC1 was O.36O .
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Table I. Data for Enzyme Content and Summary of the 
Effect of ATP and Mg** on Citrate Synthase.
The coupled assay procedure was used. . Each cuvette (1.0 cm light 
path) contained 0.20 M Tris-acetate buffer pH 8.1 to 8.5» 10 mM 
malate, 0.384 mM NAD, acetyl-CoA (see below), 8.0 units of MDH,
0.003 to 0.007 units of citrate synthase from the tissue indicated, 
ATP and Mg** as indicated and water to 1.0 ml final volume.
For the determination of enzyme content and the effect of 
Mg on ATP inhibition, the acetyl-CoA concentration used in a 
given experiment was constant; variation in the concentration of 
acetyl-CoA from one experiment to another was from 3*5 to 9 times 
the Km for acetyl-CoA. To determine Km and Ki, acetyl-CoA was 
used over a concentration range of 2 to 20 x Km in each experiment.
♦The extent of disruption of yeast cells during homogenization 
was not determined by microscopic examination of the homogenate; the 
breakage was probably partial and thus the reported values of enzyme 
content of yeast are probably low.
Those values followed by (c) have been calculated by computer 
as explained in A. METHODS 5)•
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Table I ■
a b c
Tissue Crude Total Units Protein Specific Activity
Extract Gram wet weight mg/ml units/mg 
of tissue
rat liver 3<>l6 17.61s. 0.033
rat heart 28.50 7.88 0.738
rat kidney 7.88 11.08 0.132
rat brain 1+.66 5*77 0.176
beef liver 1.18 13.80 0.020
beef heart l805l 5.1+7 ‘ 0.629
^ aerobic yeast5^ 0.71+ 1.67 0.095
anaerobic 1066 7.89 0.01+5
oo yeast'
IA»
d e f g h i
Km x 10* Ki x 103 Per cent Activity with Mg*'*' ’ ~ 
moles moles 5mM ATP IQmM ATP
litre litre ho Mg+'r5mil Mg’*"*' Ko Mg^lQmM Mg1*'
0.88(c) 0.52(c) ■1+7.7 91.8 1+3.6 81.1+
1.73(c) 0.72(c) 52.8 92.1 1+1+.3 90.1
1.90(c) 1.13(c) 51+.5 91.3 36.7. 81.0
0,7>+(c) 0.1+9 51+.6 80.6 1+6.9 75.0
2.01 3.69 73.1 86.2 66.6 80.2
1.1+0 2.82 • 7U *6 91 o 9 62.3 83.1+
1.12 0.1+9 71.6 87.9 60.5 76.5
0.15(c) 0.59(c) 68.1 77.0 1+9.2 62.3
PO
Vj\
Table II. (from 69) Total Weight and Percentage 
Distribution of Metals in Rat Liver Fractions.
Values shown are the means of values obtained from examination 
of livers from five groups of rat livers each of which is 
composed of a sample of tissue from five animals. Fractionation 
of cellular components was carried out by the method of 
Hogeboom et al.(?0). Emission spectrography was used to 
determine the metals.
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Table II
N
In­
organic
4th
Cu Mu Zn Ca Fo M C Ha K
• T o ta l w eight in wholo liv e r, y  per gin. fresh perfused tissue
M e a n ...................
±  standard
19,800 12,000 4.7 1.3 15 17.4 22.0 100 270 2900
e rro r ........... ± 2 ,0 0 0 ± 2 0 0 ± 0 .4 7 ± 0 .1 5 ± 1 .3 ± 5 .1 ± 2 .2 ± 1 9 ± 1 4 ±1 8 0
D is tr ib u tio n  in fractions, per cent
Connective
tissue . . . . . 6 .3 2 .8 2 .2 2.1 2 .4 4 .2 2 .2 2 .0 2 .2 2 .0
N ucle i and
whole cell
residue........... 43.9 37.4 20.3 OS.8 37.2 45.0 24.4 47.8 25.8 29.0
M ito c h o n d ria .. 12.4 5.1 8 .2 15.1 4 .6 28.2 11.2 17.4 2 .7 7 .8
M icrosom cs. . . 10.7 7 .3 5 .0 0 .4 12.9 11.9 15.0- 13.7 3 .2 2 .8
S u p e rn a ta n t.. . 27.7 47 .5 04 .3 7 .5 43 .2 10.7 47.1 19.2 00.1 58.0
—
T h e  sum of tho fractions •* tho whole liv e r reconstituted *=* 100 ± 0 .5  per cent.
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CHAPTER 3
DISCUSSION
A. MECHANISM OF CITRATE SYNTHASE INHIBITION BY ATP
ATP inhibition of CS from a variety of tissues has been reported 
(24,54,60,61,62,63)• Kosicki and Lee (59) observed inhibition of a 
purified pig heart CS by nucleoside di- and triphosphates, NADH, NADPH 
and CoA. This inhibition was competitive with respect to acetyl-CoA, 
Examination of the structure of the inhibitory molecules as well as that 
of acetyl-CoA revealed that a polyphosphate group and a purine residue 
W8re common to them. However, a lack of inhibition by 5*-AMP and 3'»5'- 
cyclic AMP, appears to rule out the direct participation of the purine 
residue in the observed inhibition of CS, Accordingly, experiments were 
carried out to see whether inorganic pyrophosphate were inhibitory to CS, 
Inorganic pyrophosphate inhibited CS and this inhibition was competitive 
with respect to acetyl-CoA; this was not an ionic strength effect (65),
We have studied this behavior using crude extracts. Crude 
extracts were used since they probably most closely approach physiological 
conditions. Concentrations of ATP approximately one hundred times that 
of acetyl-CoA are competitive with respect to acetyl-CoA in their 
inhibition of CS, This was observed' Using crude dialysed extracts of 
rat liver, heart, kidney and brain; beef liver and heart; and aerobically 
and anaerobically grown yeast cells (Fig, i and Table I, columns f and h). 
Other workers (64) have recently reported similar results: ATP inhibition 
of CS purified from beef liver and heart is competitive with respect to 
acetyl-CoA. However, ATP does not inhibit competitively with respect to 
acetyl-CoA in a reaction catalysed by Escherischia coli CS. Mg++ inhibits
28 .
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this enzyme and relieves ATP inhibition (6^), ATP inhibition of CS from 
rat liver mitochondria was reported (62) not to be competitive with 
acetyl-CoA. This finding is not in agreement with our observation that 
CS in a crude extract of rat liver is competitively inhibited by ATP,
Divalent metal ions when present in one hundred fold excess over 
acetyl-CoA have been reported to be inhibitory to the reaction catalyzed 
by pig heart CS (59). This inhibition is not competitive with respect 
to OAA but is reduced by an increased concentration of acetyl-CoA.
Moreover, concentrations of divalent metal ions lower than or equal to the 
ATP concentration, relieve the ATP inhibition (59). We observed similar 
behavior using crude extracts of tissues (Table I), Increasing concen­
trations of Mg++ are inhibitory to CS (Fig. 3» upper curve). In the 
presence of 5 and 10 mM ATP, the CS activity increases as higher con-
f -
centrations of Mg are used and maximum activity is reached when the ATP
concentration is approximately equal to the Mg++ concentration (Fig, 3»
two lower curves). That the ATP-Mg complex is not measurably inhibitory
to the CS reaction is shown in Fig. k, A comparison of Figs. 2 and h-
“H"clearly points out that Mg does prevent ATP from inhibiting the enzymatic 
condensation of OAA with acetyl-CoA. Results obtained from pH titration 
experiments (71) suggest that metal ions chelate with the polyphosphate 
moiety of adenosine phosphates. The chelation of divalent metal ions 
with the polyphosphate portion of acetyl-CoA would explain the inhibitory 
effect of metal ions on the CS reaction if the polyphosphate of acetyl-CoA 
becomes necessarily associated with the enzyme-OAA complex during the 
reaction. The inhibitory effect of inorganic pyrophosphate and its 
derivatives on the CS reaction could then be interpreted to be due to 
the binding of their polyphosphate group at a site on the enzyme where
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the polyphosphate of acetyl-CoA normally becomes bound. The chelation of 
metal ions with these polyphosphate derivatives would block their ability 
to inhibit the CS reaction. This would account for the observed decrease 
in nucleotide inhibition of CS on addition of divalent metal ion.
In summary, evidence from previous work indicates that OAA becomes 
bound to CS by both carboxyl groups and by the carbonyl oxygen (^0). It 
appears that the keto form of OAA (33*^8) is the substrate for CS. Of 
interest in this regard is the recent finding of an enzyme which catalyzes 
the tautomerization of OAA (72). The binding of OAA to enzyme is accom­
panied by a change in conformation of CS (^0), Since the binding of OAA 
(or malate) is necessary for loss of a proton from the methyl group -of 
acetyl-CoA, it is possible that the conformational change in CS which 
occurs upon binding to OAA, causes either the carboxyl groups of OAA or 
some groups on the protein to be in a favorable spatial arrangement in 
order that electronic effects on an q(-proton of acetyl-CoA enhance its 
removal in a rate-limiting step. After the -proton of acetyl-CoA has 
been removed, a nucleophilic attack of the carbanion on. the carbonyl of 
OAA takes place with simultaneous hydrolysis of the thioester bond.
These findings suggest that acetyl-CoA becomes bound to the enzyme at its
4-1
polyphosphate group. Thus, added Mg binds with the polyphosphate chain 
of acetyl-CoA and prevents binding of substrate with enzyme. In the 
presence of an inhibitor such as ATP, Mg++ binds to the polyphosphate 
moiety of this molecule and prevents it from occupying the acetyl-CoA 
binding site. Comprehensive reviews of the mechanism may be found 
elsewhere (^8,73)•
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B. METABOLIC CONTROL OF CITRATE SYNTHASE
The discussion of metabolic control is organized as follows:
1) General principles of metabolic control
2) Observations and proposals related to in vivo control of CS by
a) Citrate
b) Acetyl-CoA
c) Palrai to yl-> Co A.
d) Fatty acids
e) OAA
f) Metal ions
3) Reported in vitro findings related to adenine nucleotides 
and Mg++ effects on enzymes and in particular CS
k) An analysis of our experimental data under the following 
headings:
a) Enzyme Content
b) Km and Ki values
c) Magnesium ion relief of ATP inhibition
d) Effect of the ATP-Mg complex on CS
5) The results of in vivo studies and a conclusion concerning 
the control of CS by ATP
1) Principles of Control of CS
Metabolic pathways are successive conversions of molecules in 
biological systems. More elaborate metabolic schemes are usually found
in those organisms which readily adapt to new sources or to a wider 
variety of compounds; these are used for fuel or for building blocks 
during synthesis and maintenance of cellular structure and function.
Each pathway evolves to fill a need and therefore has specific, often 
vital, functions. Thus, at this stage another level of organization 
develops which integrates all the pathways enabling them to coexist to 
the advantage of the organism. This force which serves to coordinate 
all processes is metabolic control.
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The rate of conversion of metabolites is regulated by enzymes. 
Each enzyme carries out a particular alteration in a molecule and so the 
product of one reaction is the substrate for the next. Then changing 
the ability of an enzyme to catalyze a reaction, results in an altered 
rate of metabolism. The rate at which a metabolic reaction takes place 
is governed by the amount of the required enzyme present and by the 
activity of those enzyme molecules. Thus, control of the reaction may 
take place along two lines. One is the regulation of synthesis and 
degradation of the enzyme and another is the availability of effectors 
(activators or inhibitors), substrate(s), and cofactors. The latter is 
the type of metabolic control under consideration in this discussion,
2) Control of CS
a) Citrate; In addition to its well known role in the tri­
carboxylic acid cycle, the following metabolic functions for citrate 
have been suggested by Srere from in vitro studies (7*0; a) a source of 
reducing power b) a source of acetyl groups and c) a controller of 
enzyme activity, a) Citrate may be transported out of the mitochondria 
to the cytoplasm where its conversion to o(-ketoglutarate by means of 
aconitase and isocitrate dehydrogenase results in the reduction of NADP, 
a process necessary to have hydrogen available for synthetic reactions 
in the cytoplasm (Diagram 3)• b) Srere and Bhaduri (75) showed that' 
citrate could contribute to the acetyl-CoA pool and subsequently be used 
for fatty acid synthesis. The amount of citrate cleaved to OAA and 
acetyl-CoA depended on the availability of free acetate for acetyl-CoA 
formation, c) In addition to acting as an acetyl donor in fatty acid 
synthesis, citrate has been reported to activate acetyl-CoA carboxylase. 
Citrate (or isocitrate) was required for the carboxylation of acetyl-CoA
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to form malonyl-CoA in liver extracts (57) and either of these compounds 
could stimulate this activity in other tissues (58). The reaction 
catalyzed by acetyl-CoA carboxylase has been shown to be rate limiting 
(57.76,77,78). Therefore, it has been suggested that the rate of fatty 
acid synthesis is regulated by the intracellular concentration of citrate 
(79,80). If this is true, either the citrate content of liver might be 
expected to parallel acetyl-CoA carboxylase activity or the activity of 
this enzyme could be regulated by intracellular compartmentalization of 
citrate. Chance et al., (81) warn that the total cell concentration of 
a metabolite is an average of the concentrations in organelles. This 
kind of analysis ignores transport of metabolites and may be meaningless 
in terms of studying metabolic control.
Experiments have shown that changes in citrate content of liver 
tissue are negligible when the nutritional state of the animal causes an 
alteration of fatty acid synthesis (82). Recently, Swanson et al.. (83) 
have reported that rat liver acetyl-CoA carboxylase is activated by 
incubation at 26°C. The presence of citrate during incubation resulted 
in greater activity. More conclusive evidence for the role of citrate 
(or isocitrate) in the activation of acetyl-CoA carboxylase has come 
from the work of Ryder et al., (84) who used the enzyme from chicken liver. 
It appears that citrate induces a conformational change in the protein 
so that transfer of CO2 from the enzyrae-biotin complex to acetyl-CoA is 
activated.
Since NADPH is required for fatty acid synthesis, citrate stimu­
lation of fatty acid synthesis could be accounted for by its positive 
effect on NADPH formation. However, citrate has been shown to be a 
better activator than other NADPH-generating systems (56),
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Citrate (and fumarate) was observed to inhibit pig heart mito­
chondrial MDH and was competitive with NADH (85)* Compounds not showing 
inhibition were isocitrate, maleate, succinate, cis-aconitate, aspartate, 
glutamate, pyruvate and phosphoenolpyruvate. Cytoplasmic MDH was inhibited
glucose
cytoplasmic MDH
OAA-malate -%~
A-NADP NAD acetyl-CoANADH
malonyl-CoAcitrate 
cleavage 
enzyme.
malic enzyme
free fatty 
acids
NADPH
ATP,CoA
pyruvate^— >  acetyl-CoA
citrate..citrate
cis-aconitatecis-aconitate
MDH
isocitrateisocitratepyruvate
>  NADPH
oxalo succinateoxalo succinatemalate
>- -ketoglutarateV  < -cK -ketoglutarate
MITOCHONDRIA CYTOPLASM
Diagram 3
by none of these compounds. This has been considered a possible means 
whereby citrate regulates fatty acid synthesis in the cell. The inhibi­
tion of mitochondrial MDH by citrate prevents the formation of maleate 
from OAA (favored by equilibrium) in the mitochondria (Diagram 3) • OAA 
does not diffuse readily from the mitochondria (86). OAA along with 
acetyl-CoA in the mitochondria is converted by means of CS to citrate; 
this compound is transported into the cytoplasm where cleavage yields 
acetyl-CoA for fatty acid production and OAA. The OAA may be converted
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to pyruvate by the action of cytoplasmic MDH and malic enzyme. In this 
way NADPH as well as acetyl-CoA become available for cytoplasmic fatty 
acid synthesis, Srere and Foster (53) observed that a twenty-four hour 
fast caused a virtual cessation of fatty acid synthesis in rat liver.
There was a four-fold increase in the blood acetoacetate level. Citrate 
cleavage enzyme activity rose reaching a maximum after twelve hours 
without foodc After twenty-four hours the activity of this enzyme in the 
livers of starved animals was no lower than that of fed animals. The CS 
activity level increased by approximately twenty-five per cent. These 
results indicate that a change in citrate cleavage enzyme level is not 
directly the cause of change in fatty acid metabolism during starvation, 
Shrago et al., (87) found that citrate cleavage enzyme, assayed according 
to the method of Srere (88), was absent from human adipose tissue. It is 
possible that fatty acids are not made in human adipose tissue; trigly­
cerides made in the liver where citrate cleavage enzyme is found (87)nay 
be transported in the blood to adipose tissue.
Citrate and isocitrate are the only tricarboxylic acid cycle 
intermediates that inhibit pho sphoglucomutase, The inhibition appears 
to be due to the removal, by chelation, of %  which is necessary for 
enzyme activity (89 ), This is similar to the effect of citrate on 
phosphofructokinase (90).
b) Acetyl-CoA: Acetyl-CoA is an important metabolic intermediate.
The control of reactions in which it participates determines whether 
it is sent into the production of energy (tricarboxylic acid cycle), 
fatty acids, keto acids or glucose, Acetyl-CoA itself may function as 
an effector of enzyme activity. Acetyl-CoA is competitive with respect 
to CoA in the pig heart pyruvate dehydrogenase reaction (91), Acetyl-CoA
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has been demonstrated to be an activator of pyruvate carboxylase. This 
enzyme is present in liver (92) and adipose tissue (93) in equal amounts. 
Thus acetyl-CoA activation of pyruvate carboxylase could lead to the 
conversion of pyruvate to fatty acids. During glycolysis coenzymes are 
reduced. Fatty acid synthesis could function to oxidize these coenzymes 
so that glucose would continue to be converted to acetyl-CoA (9*0« In 
the presence of a transhydrogenase system to convert NADH to NADPH, NAD+ 
is made available for continual glycolysis and acetyl-CoA production and 
acetyl-CoA reduction to fatty acids by NADPH is enhanced.
Alternatively, activation of pyruvate carboxylase by acetyl-CoA 
(95) in liver, when considered with the acetyl-CoA inhibition of pyruvate 
kinase and glucokinase (96), could be interpreted as a mechanism to 
stimulate gluconeogenesis.
c) Palmitoyl-CoA: CS (**5,97) and acetyl-CoA carboxylase are 
reported to be inhibited by palraitoyl-CoA and other long-chain acyl 
coenzyme A derivatives (98); only long-chain fatty acyl carnitine 
derivatives relieve this inhibition (99*100), However., in vivo studies 
show that increased levels of palmitoyl-CoA are associated with increased 
citrate levels (101,102,103). Moreover, the decrease in liver citrate, 
level on fasting was not large enough to account for the observed decrease 
in liver fatty acid synthesis. Srere (**5) has suggested that palmitoyl-CoA 
does represent a physiologically significant control of metabolism.
This view is supported by the observation that palmitoyl-CoA is a non­
specific inhibitor of many enzymes (10*0.
d) Fatty Acids: The inhibition of enzymes by fatty acids may 
be a widespread phenomenon used by the cell to regulate metabolism. Lea 
and Weber (**7) report that octanoate inhibits key enzymes in glycolysis.
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Th© levels of octanoat© required for the above observations were high, 
however, and make it an unlikely in vivo regulator. Longer chain fatty 
acids inhibited at concentrations within tho physiological range (^7).
e) OAA: The fates of oxalacetate within the cell have recently 
been reviewed (105), OAA exists in keto and enol forms. The keto form 
has been shown to be th© tautomer that binds to CS (33) and others have 
suggested (106) that the enol fora of OAA inhibits succinic dehydrogenase. 
The fact that the in vivo steady state concentration of OAA is much lower 
than that of other tricarboxylic acid cycle intermediates (107) and the 
discovery of an enzyme that catalyzes the tautomerization of OAA (72), 
suggest a possibility for metabolic control by OAA.
In rat liver, the carboxylation of pyruvate is the major source 
of OAA. In beef liver, it is the conversion of propionate to OAA within 
the mitochondria.
f) Metal Ions: It is known that metal ions and protons are trans­
ported between the mitochondria and cytoplasm sometimes against concen­
tration gradients (108,109,110,111,112). Mg** has been shown to alter
the movement of citrate into and out of mitochondria (113) and Mg** is 
present in relatively high concentration compared to other divalent 
cations (69, Table 2).
‘At physiological pH, ATP is predominantly in the tetraionic form
(11^). When equimolar solutions of MgCl2 and ATP“^ were mixed in vitro.
2
the concentration of the complex, MgATP , approached the initial concen­
tration of ATP”^ used (115,116) because of the apparent formation constant 
for MgATP”^ (e.g. 3100 moles-* litre (117,118)). From independent reports 
of the quantities of Mg** (69) and ATP (119) in rat liver, the ratio of 
Mg**/ATP has been calculated to be 2.6 for whole cells. Similarly, the
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ratio of Mg**/ATP in rat liver mitochondria is calculated to be 9.0 (69, 
120,121). Moreover, Ca** is also present in high levels in mitochondria 
(Table II) and forms an even more stable complex with ATP (71). Thus, the 
amount of "free" ATP in the mitochondria may be very low. ATP has been 
observed to inhibit swelling of mitochondria in vitro (122)♦ It may be 
that the concentration of divalent metal ion in the cell is regulated by 
the ATP level.
3) Control of CS bj ATP?
It appears that substrates and products of the CS reaction may 
be widely distributed in the control of metabolism. A reasonable assump­
tion would be that CS itself is under careful metabolic control. Initial 
observations that adenine nucleotides inhibit CS led Atkinson et al. (5**, 
60,62) to postulate that the energy level of the cell (reflected by the 
ATP level) acts in a feedback mechanism to control the direction of 
acetyl-CoA utilization. When the ATP level in the cell is high, CS is 
inhibited and acetyl-CoA is prevented from entering the tricarboxylic acid 
cycle and from contributing to ATP production via electron transport. 
Investigation of beef heart and beef liver enzymes led th© Atkinson group 
(6*0 to reaffirm their-proposed regulation of CS by the "energy charge" 
of the cell (123) expressed in the ratio ATP + -§ADP/AMP + ADP + ATP. All 
observations to date have demonstrated that ATP inhibits CS from a number 
of sources (2*t,5^,59.60,61,62,63,6^,65,12*0 • Our results as reported 
here are in agreement in this respect (Table I, columns d and e,f and h). 
Th© effect of AMP on CS has been reported as negligible for the pig 
heart enzyme (65) and low for the beef liver and beef heart enzymes (6*+).
AMP stimulation of NAD-specific isocitrate dehydrogenase (125) 
supports this reasoning. A similar mechanism appears operative for
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phosphofructkinase, an enzyme which is inhibited by ATP; 3,*5'-cyclic AMP, 
.5*-AMP and ADP overcome this inhibtion (126),
f^) Analysis of Our Data
In light of these observations, i^seemed important to examine 
the inhibtion of CS by ATP and the effect of Mg** on this inhibition.
Crude extracts were used in order to minimize alteration of the behavior 
of CS. To approach physiological conditions in one respect, the divalent 
metal ion, Mg , was added to the in vitro system. Tissues were chosen 
so that results could be compared with previous observations. More than 
one species and different tissues within a species were examined for 
differences in CS characteristics.
a) Enzyme Content: Heart tissue contains more CS activity than
other tissues. This would be expected for a rapidly respiring tissue. 
Anaerobic yeast may have more CS activity than aerobically-grown cells 
(See legend to Table I*). This possibly indicates that the citrate 
produced acts in a capacity to furnish NADPH (via isocitrat© dehydrogenase, 
see Diagram 3) for fatty acid synthesis. .
b) Km and Ki values: ATP inhibition of CS is competitive with
respect to acetyl-CoA in each of these tissues. The Km values in Table I 
(column d) show that in the rat, liver and brain CS have lower Km values 
(about ■§) than kidney and heart (i.e. concentrations of acetyl-CoA 
required for half saturation of the enzyme). The liver and brain enzymes 
are inhibited to about the same extent by ATP (column e). Rat heart CS 
requires a higher level of ATP for inhibition. Rat kidney CS is inhibited 
when ATP levels are about twice those required for the same amount of CS 
inhibition in rat liver and brain. Beef heart and beef liver CS show 
inhibition at relatively higher levels of ATP. Beef heart CS has a lower
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Kin for acetyl-CoA than beef liver CS. In the anaerobic yeast not only 
is CS present to the extent of more than double the activity compared 
to the enzyme in aerobically-grown yeast but it requires only 12 to 15 
per cent the amount of acetyl-CoA needed for half maximal reaction in 
the aerobic yeast CS reaction. This could mean that in the aerobic 
system more acetyl-CoA is produced because more reaction pathways are 
open for acetyl-CoA utilization and an active control system probably 
determines the amount of acetyl-CoA entering the tricarboxylic acid cycle. 
Aerobic CS does not have to operate as efficiently as the anaerobic CS 
since substrates may be present in higher concentrations. The lower rate 
of glycolysis expected in anaerobic yeast and the production of ethanol 
from pyruvate may be partially compensated for by having a lower threshold 
of acetyl-CoA concentration for citrate formation. In Table I, by comparing 
columns f and h, it is seen that higher concentrations of ATP cause more 
inhibition of CS in all tissues.
c) Magnesium Ion Relief of ATP Inhibition: Figure 3 is qualitatively
representative of results observed for CS in each of the extracts assayed.
4*+
The presence of Mg causes a reversal of ATP inhibition and it appears
that most relief occurs when the Mg concentration equals that of the
++inhibitor, ATP; this reversal by Mg is seen in Figure 3 and also in
Table I by comparing column f with g and h with i. Similar observations
have been made using Ca instead of Mg (59)•
d) Effect of the ATP-Mg Complex on CS: In order to observe the
4~4*
effect of ATP on CS in the presence of an equal amount of Mg , experiments 
were carried out over a wide range of ATP concentrations under the
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condition of increasing concentrations of ATP and Mg at a fixed molar 
ratio of one to one. Results of experiments run at constant ionic strength
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show that the ATP-Mg complex does not inhibit beef heart CS (Fig, 4),
Similar results were found using crystalline pig heart CS, It follows
that the values for per cent activity in columns g and i (Table I)
should approach one hundred since the ATP-Mg complex does not inhibit CS.
The observed differences might be explained in terms of the following
consecrations; In those experiments reported in Table I, the ionic
strength varied according to the amount of ATP present. This was
compensated for by using a "standard curve" of per cent activity versus
ionic strength. However, the standard curve was constructed from data
obtained using crystalline pig heart CS and the response of CS in crude
extracts of other species and tissues to ionic strength changes are not
necessarily the same. Another possible explanation might be that the
++
competition for Mg between ATP and other compounds present, especially 
acetyl-CoA, may vary with ionic strength. This would affect the amount 
of "free" ATP.
5) Inj^y/o Studies
Mg has been shown to change the pH optimum of plant alkaline 
fructose diphosphatase (127) and may have a role in the determination of 
stereospecific structure during enzymatic reactions (128),
The observation that ATP is not inhibitory to CS when bound to 
Mg++ (Fig. k) and the fact that Mg** levels in the cell are high (Table II), 
raise doubt at this time as to the importance of ATP in the direct 
regulation of CS activity. Much of the accumulated data has been obtained 
from in vitro systems; under these conditions, the enzyme concentration 
used is usually several fold less than in vivo and in many cases this 
results in an altered behavior of the enzyme (129). Williamson et al.
(130) have carried out experiments using isolated respiring mitochondria.
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The results suggest that CS activity is not significantly controlled by 
the concentration of ATP in the mitochondria; the redox state of pyridine 
nucleotides in the mitochondria appears to control the rate of the CS 
reaction by regulating the formation of OAA and its availability for 
condensation with acetyl-CoA.
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CHAPTER k
SUMMARY
In rat tissues, heart contains considerably more (k to 7 times) 
CS activity than liver, kidney or brain. Beef heart is more active (15 
to 16 times) than beef liver with respect to CS activity. Anaerobic 
yeast have approximately double the CS activity found in aerobic yeast.
ATP in a concentration 20 to 200 times that of acetyl-CoA 
inhibits CS in crude extracts of several tissues. This inhibition is 
competitive with respect to acetyl-CoA. With increasing concentrations 
of ATP, a decrease in activity is observed until a minimum level of.CS 
activity is reached at 80 per cent of that observed for a control 
reaction. Variation in Km and Ki values are observed from tissue to 
tissue. There is no direct correlation between the relative amounts 
of acetyl-CoA necessary for half saturation of the enzyme (Km) and the 
amount of ATP required for 50 per cent inhibition (Ki) in the tissues 
studied. Of all these tissues, anaerobic yeast requires the least 
acetyl-CoA for half saturation of the enzyme.
Mg is inhibitory to CS when used in a concentration 100 fold 
greater than the concentration of acetyl-CoA, In low concentration, Mg 
relieves the inhibition of CS by ATP. When Mg4"* and ATP are present in 
low or high concentrations, no inhibition is observed as long as the 
molar ratio of Mg++/ATP is one. The effect of Mg4"1" appears to be the 
result of chelation of the divalent metal with the polyphosphate chain 
of molecules. In the case of acetyl-CoA, Mg chelation inhibits the
normal reaction by preventing this substrate from binding with the
-1, -1 ,
polyphosphate moiety to the enzyme. In the case of ATP, Mg chelates
43
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with the polyphosphate group of ATP and prevents It from inhibiting the 
enzymatic reaction. This information is useful to the understanding of 
the mechanism of the reaction.
The high intracellular concentration of Mg+* casts doubt upon 
the physiological importance of ATP as a regulator of CS. In vivo 
studies by other workers also indicate that ATP has no direct role in the 
regulation of CS activity.
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ZZF0RX5
DIMENSION Y (60)tX(60)
C LEAST SQUARES ANALYSIS OF 1/V VS. 1/S DATA
C PUT UNINHIBITED DATA FOR A RUN FIRST
C FOLLOWED IMMEDIATELY BY INHIBITED DATA
C R=RUN NO.
C N = NO. OF POINTS ON 1/V VS. 1/S PLOT
C Y=l/V, X=l/S
C VMAX1.UVMAX1,KM1,KI1 ARE VALUES WITH THE MAXIMUM +VE STANDARD
C ERRORS CARRIED THRU THE CALCULATION^
I JK= O
1 READ 2.R.N
2 FORMAT(A3. 14 >
IF(N — 9999 > 3,8,3
3 READ 4, (Y(I)«X(I).1=1iN)
4 FORMAT(6(F5.1 .F6.0) )
SX = 0.
SY = 0.
SXY = 0.
SXX=0.
SYY=0. ' .
DO 5 l - l t N  .
SX=SX+X(I)
SY = SY+Y< I )
SXY = SXY +X( I ) *Y( I )
SXX-SXX+XCI )*X( I )
SYY=SYY+Y(I)*Y(I)
5 CONTINUE 
C = N
IF(IJK)7.6.7
6 USLOPE=(SX*SY-C*SXY)/(SX*SX-C*SXX>
UYINT=(SX*SXY-SXX*SY)/ (SX*SX-C*SXX)
UXINT=-UYINT/USLOPE
AKM = - 1./UXI NT 
UVMAX =1 ./UYINT
U S T D E Y = ( ( 1 . / C ) * S Y Y - ( S Y / C ) * * 2 ) * * 0 . 5  
U S T D E X = ( < l . / C ) * S X X —( S X / C ) * * 2 ) * * 0 . 5  
U R R = ( < 1 . / C ) * S X Y - ( S X / C ) * ( S Y / C ) ) / ( U S T D E Y * U S T D E X )
I JK= I Jl<+ 1
IF(URR— 1•) 20,21.21 
20 USTERY=USTDEY*<1.-<URR*URR))**0.5 
USTERX=USTDEX*(1,-(URR*URR))**0.5 
AKM1=-1 «/(UXI NT + USTERX)
UVMAX1 = 1./(UYINT+USTERY) .
GO TO 1
7 SLOPE= (SX*SY-C*SXY)/(SX*SX-C*SXX)
Y I NT = (SX*SXY —SXX*SY)/(SX*SX—C*SXX)
XINT = -YI NT/SLOPE
VMAX-1./YINT
Bl< I =-0. 005*AKM*X INT/( 1 .+AKM*X INT )
C N.B.****0.005=INHIdITOR CONCENTRATION IN MOLES/L
STDDEY=((1./C)*SYY-(SY/C}**2)**0.5 
STDDEX=((1./C)*SXX-(SX/C)**2)**0.5 
RR= ((l./C) *SXY- ( SX/C) * ( SY/C ) ) / ( ST.DOEY*STDDEX )
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I JK-0 
IFCRR-1.) 22,21.21
22 STDERY = STDDEY* ( 1 • — ( RR-*RR ) )**0.5 
STDERX=STDDEX*( 1 ,-!RR*RR) ) **0 . 5 
VMAX1 = 1 •/!YlNT + STDERY>
SKI 1 =(-0.0 05*AKMl*tXINT-STDERX) )/( 1 »+ AKM1*(X INT-STDERX) ) 
PUNCH 10 0,R
100 FORMAT(8HRUN N0.=,A3)
PUNCH 202,URR
202 F O R M A T (37HC0RRELATI ON COEFFICI E N T !UN INHIBI T E D > = *E 1O .3)
PUNCH 203,RR
203 FORMAT(35HCORRELATI ON COEFFICI ENT( INHIoI TED)=,E 10.3>
PUNCH 205,USTERY,USTERX
205 FORMAT!5HUERY=,El 0.3,5X,5HUERX=,E10.3)
PUNCH 204,STDERY,STDERX
204 F0RMAT(4HERY=,E10.3,5X,4HERX=,E10.3)
PUNCH 200.UVMAX1,AKM1
200 FORMAT!37X.7HUVMAX1=,E 10.3,2 X,4HKM1=,El0.3)
PUNCH 101 ,UYI NT,UX INT,UVMAX,AKM
101 FORMAT ( 6HUY INT=*E10.3»3X,6HUXINT=,E10.3,3X, 6HUVMAX= , E 1 0 » 3 , 3 X , 3H.- 
= , E 1 0 • 3 )
PUNCH 201 , VMAX1 ,BI<I 1
201 FORMAT!38X.6HVMAX1=,E 10.3,2X ,4HKI 1 = ,E10.3)
PUNCH 102»YINT,VMAX,BKI
102 FORMAT! 1X ,SHY I NT=♦E 10.3,23X,5HVMAX=,E 10.3,3X,3HK1 -,E 10.3//)
GO TO 1
21 PUNCH 300,R 
300 FORMAT!A3.5X,15HCANN0T EVALUATE)
25 GO TO 1 
8 CALL EXIT 
END
ZZZZ8
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